1 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D01977
D01977
|
Gefitinib
| 1件: 75 75 |
2 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D03455
D03455
|
Cetuximab
| 5件: 34 34, 51, 86, 89, 331 |
3 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D04023
D04023
|
Erlotinib
| 1件: 94 94 |
4 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D04024
D04024
|
Lapatinib
| 3件: 34 34, 74, 75 |
5 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D07907
D07907
|
Erlotinib
| 1件: 94 94 |
6 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
7 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D11251
D11251
|
Icotinib
| 1件: 34 34 |
8 |
EGFR
| 14件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
9 |
GUCY1A2
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion | D00517
D00517
|
Amyl Nitrite
| 1件: 58 58 |
10 |
GUCY1A2
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
11 |
GUCY1A1
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion | D00517
D00517
|
Amyl Nitrite
| 1件: 58 58 |
12 |
GUCY1A1
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
13 |
GUCY1B1
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion | D00517
D00517
|
Amyl Nitrite
| 1件: 58 58 |
14 |
GUCY1B1
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
15 |
KCNJ3
| 3件: Retrograde endocannabinoid signaling Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway | D00636
D00636
|
Amiodarone
| 2件: 28 28, 127 |
16 |
KCNJ3
| 3件: Retrograde endocannabinoid signaling Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway | D02910
D02910
|
Amiodarone
| 2件: 28 28, 127 |
17 |
KCNJ5
| 3件: Retrograde endocannabinoid signaling Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway | D00636
D00636
|
Amiodarone
| 2件: 28 28, 127 |
18 |
KCNJ5
| 3件: Retrograde endocannabinoid signaling Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway | D02910
D02910
|
Amiodarone
| 2件: 28 28, 127 |
19 |
KCNJ12
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D00636
D00636
|
Amiodarone
| 2件: 28 28, 127 |
20 |
KCNJ12
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D02910
D02910
|
Amiodarone
| 2件: 28 28, 127 |
21 |
NPR1
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Thermogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion | D04051
D04051
|
Erythrityl tetranitrate
| 1件: 46 46 |
22 |
NPR1
| 6件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Thermogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion | D05147
D05147
|
Nesiritide
| 2件: 46 46, 58 |
23 |
NPR2
| 3件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Oxytocin signaling pathway | D04051
D04051
|
Erythrityl tetranitrate
| 1件: 46 46 |
24 |
NPR2
| 3件: Purine metabolism Purine metabolism, Vascular smooth muscle contraction, Oxytocin signaling pathway | D11190
D11190
|
Vosoritide
| 1件: 276 276 |
25 |
OXTR
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D00089
D00089
|
Oxytocin
| 6件: 6 6, 72, 127, 193, 206, 226 |
26 |
OXTR
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D03008
D03008
|
Atosiban
| 1件: 118 118 |
27 |
OXTR
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D07229
D07229
|
Carbetocin
| 1件: 193 193 |
28 |
PPP3CA
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00107
D00107
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
29 |
PPP3CA
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
30 |
PPP3CA
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D05480
D05480
|
Pimecrolimus
| 1件: 160 160 |
31 |
PPP3CA
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08556
D08556
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
32 |
PPP3CA
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09033
D09033
|
Voclosporin
| 1件: 222 222 |
33 |
PPP3CB
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00107
D00107
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
34 |
PPP3CB
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
35 |
PPP3CB
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D05480
D05480
|
Pimecrolimus
| 1件: 160 160 |
36 |
PPP3CB
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08556
D08556
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
37 |
PPP3CB
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09033
D09033
|
Voclosporin
| 1件: 222 222 |
38 |
PPP3CC
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00107
D00107
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
39 |
PPP3CC
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
40 |
PPP3CC
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D05480
D05480
|
Pimecrolimus
| 1件: 160 160 |
41 |
PPP3CC
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08556
D08556
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
42 |
PPP3CC
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09033
D09033
|
Voclosporin
| 1件: 222 222 |
43 |
PPP3R1
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00107
D00107
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
44 |
PPP3R1
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
45 |
PPP3R1
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D05480
D05480
|
Pimecrolimus
| 1件: 160 160 |
46 |
PPP3R1
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08556
D08556
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
47 |
PPP3R1
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09033
D09033
|
Voclosporin
| 1件: 222 222 |
48 |
PPP3R2
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00107
D00107
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
49 |
PPP3R2
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
50 |
PPP3R2
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D05480
D05480
|
Pimecrolimus
| 1件: 160 160 |
51 |
PPP3R2
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08556
D08556
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
52 |
PPP3R2
| 11件: Wnt signaling pathway Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09033
D09033
|
Voclosporin
| 1件: 222 222 |
53 |
PRKAA1
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, Thermogenesis, Oxytocin signaling pathway | D00944
D00944
|
Metformin
| 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
54 |
PRKAA1
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, Thermogenesis, Oxytocin signaling pathway | D04966
D04966
|
Metformin
| 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
55 |
PRKAA2
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, Thermogenesis, Oxytocin signaling pathway | D00944
D00944
|
Metformin
| 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
56 |
PRKAA2
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, Thermogenesis, Oxytocin signaling pathway | D04966
D04966
|
Metformin
| 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
57 |
CACNA2D3
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
58 |
CACNA2D3
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D02716
D02716
|
Pregabalin
| 5件: 13 13, 36, 46, 70, 298 |
59 |
MAP2K1
| 29件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
60 |
MAP2K1
| 29件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
61 |
MAP2K1
| 29件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
62 |
MAP2K1
| 29件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
63 |
MAP2K2
| 24件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
64 |
MAP2K2
| 24件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
65 |
MAP2K2
| 24件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
66 |
MAP2K2
| 24件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
67 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00109
D00109
|
Acetylsalicylic acid
| 15件: 13 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 |
68 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00118
D00118
|
Naproxen
| 4件: 13 13, 46, 107, 271 |
69 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00120
D00120
|
Sulindac
| 1件: 206 206 |
70 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00126
D00126
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 |
71 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00130
D00130
|
Diflunisal
| 1件: 28 28 |
72 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00132
D00132
|
Ketoprofen
| 1件: 46 46 |
73 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00141
D00141
|
Indomethacin
| 3件: 225 225, 271, 298 |
74 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00217
D00217
|
Acetaminophen
| 18件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
75 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00315
D00315
|
Etodolac
| 1件: 46 46 |
76 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00330
D00330
|
Flurbiprofen
| 3件: 13 13, 21, 46 |
77 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00428
D00428
|
Salsalate
| 1件: 5 5 |
78 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00567
D00567
|
Celecoxib
| 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
79 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00568
D00568
|
Rofecoxib
| 1件: 46 46 |
80 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00813
D00813
|
Ketorolac
| 2件: 70 70, 226 |
81 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00903
D00903
|
Diclofenac
| 5件: 13 13, 34, 46, 78, 271 |
82 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00904
D00904
|
Diclofenac
| 5件: 13 13, 34, 46, 78, 271 |
83 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D00969
D00969
|
Meloxicam
| 4件: 46 46, 49, 271, 296 |
84 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D01049
D01049
|
Nimesulide
| 1件: 46 46 |
85 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D01122
D01122
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 |
86 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D01183
D01183
|
Tolfenamic acid
| 1件: 5 5 |
87 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D01475
D01475
|
Flurbiprofen
| 3件: 13 13, 21, 46 |
88 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D01545
D01545
|
Aceclofenac
| 1件: 46 46 |
89 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D01565
D01565
|
Indomethacin
| 3件: 225 225, 271, 298 |
90 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D02110
D02110
|
Indomethacin
| 3件: 225 225, 271, 298 |
91 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D02290
D02290
|
Flurbiprofen
| 3件: 13 13, 21, 46 |
92 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D02709
D02709
|
Valdecoxib
| 1件: 46 46 |
93 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D03710
D03710
|
Etoricoxib
| 2件: 46 46, 271 |
94 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D03714
D03714
|
Lumiracoxib
| 1件: 46 46 |
95 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D03716
D03716
|
Parecoxib
| 2件: 46 46, 271 |
96 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D04490
D04490
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 |
97 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D06606
D06606
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 |
98 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D07816
D07816
|
Diclofenac
| 5件: 13 13, 34, 46, 78, 271 |
99 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D08104
D08104
|
Ketorolac
| 2件: 70 70, 226 |
100 |
PTGS2
| 9件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer | D08149
D08149
|
Loxoprofen
| 2件: 46 46, 271 |
101 |
RAF1
| 26件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D06272
D06272
|
Sorafenib
| 2件: 34 34, 86 |
102 |
RAF1
| 26件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
103 |
ROCK1
| 12件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Pathways in cancer, Proteoglycans in cancer | D07941
D07941
|
Fasudil
| 4件: 2 2, 5, 7, 51 |
104 |
SRC
| 15件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D03252
D03252
|
Bosutinib
| 2件: 2 2, 67 |
105 |
SRC
| 15件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
106 |
SRC
| 15件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
107 |
SRC
| 15件: Rap1 signaling pathway Rap1 signaling pathway, VEGF signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Relaxin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis, Proteoglycans in cancer | D09664
D09664
|
Saracatinib
| 3件: 6 6, 89, 272 |
108 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00349
D00349
|
Isradipine
| 1件: 6 6 |
109 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
110 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
111 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00615
D00615
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
112 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00616
D00616
|
Diltiazem
| 3件: 51 51, 58, 86 |
113 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00617
D00617
|
Nicardipine
| 2件: 70 70, 86 |
114 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00619
D00619
|
Verapamil
| 3件: 96 96, 140, 167 |
115 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
116 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
117 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D02356
D02356
|
Verapamil
| 3件: 96 96, 140, 167 |
118 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D02914
D02914
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
119 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D03830
D03830
|
Diltiazem
| 3件: 51 51, 58, 86 |
120 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D05442
D05442
|
Perhexiline
| 2件: 58 58, 272 |
121 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
122 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
123 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
124 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
125 |
CACNA1C
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D08441
D08441
|
Propiverine
| 1件: 226 226 |
126 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00349
D00349
|
Isradipine
| 1件: 6 6 |
127 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
128 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
129 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00615
D00615
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
130 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00616
D00616
|
Diltiazem
| 3件: 51 51, 58, 86 |
131 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00617
D00617
|
Nicardipine
| 2件: 70 70, 86 |
132 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D00619
D00619
|
Verapamil
| 3件: 96 96, 140, 167 |
133 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
134 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
135 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D02356
D02356
|
Verapamil
| 3件: 96 96, 140, 167 |
136 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D02914
D02914
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
137 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D03830
D03830
|
Diltiazem
| 3件: 51 51, 58, 86 |
138 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D05442
D05442
|
Perhexiline
| 2件: 58 58, 272 |
139 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
140 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
141 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
142 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
143 |
CACNA1D
| 9件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases | D08441
D08441
|
Propiverine
| 1件: 226 226 |
144 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00349
D00349
|
Isradipine
| 1件: 6 6 |
145 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
146 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
147 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00615
D00615
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
148 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00616
D00616
|
Diltiazem
| 3件: 51 51, 58, 86 |
149 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00617
D00617
|
Nicardipine
| 2件: 70 70, 86 |
150 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00619
D00619
|
Verapamil
| 3件: 96 96, 140, 167 |
151 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
152 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
153 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D02356
D02356
|
Verapamil
| 3件: 96 96, 140, 167 |
154 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D02914
D02914
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
155 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D03830
D03830
|
Diltiazem
| 3件: 51 51, 58, 86 |
156 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D05442
D05442
|
Perhexiline
| 2件: 58 58, 272 |
157 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
158 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
159 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
160 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
161 |
CACNA1F
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D08441
D08441
|
Propiverine
| 1件: 226 226 |
162 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00349
D00349
|
Isradipine
| 1件: 6 6 |
163 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
164 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
165 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00615
D00615
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
166 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00616
D00616
|
Diltiazem
| 3件: 51 51, 58, 86 |
167 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00617
D00617
|
Nicardipine
| 2件: 70 70, 86 |
168 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D00619
D00619
|
Verapamil
| 3件: 96 96, 140, 167 |
169 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
170 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
171 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D02356
D02356
|
Verapamil
| 3件: 96 96, 140, 167 |
172 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D02914
D02914
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
173 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D03830
D03830
|
Diltiazem
| 3件: 51 51, 58, 86 |
174 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D05442
D05442
|
Perhexiline
| 2件: 58 58, 272 |
175 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
176 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
177 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
178 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
179 |
CACNA1S
| 7件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Oxytocin signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases | D08441
D08441
|
Propiverine
| 1件: 226 226 |
180 |
CACNA2D1
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
181 |
CACNA2D1
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D02716
D02716
|
Pregabalin
| 5件: 13 13, 36, 46, 70, 298 |
182 |
CACNA2D1
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D11203
D11203
|
Mirogabalin
| 1件: 70 70 |
183 |
CACNA2D2
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
184 |
CACNA2D2
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D02716
D02716
|
Pregabalin
| 5件: 13 13, 36, 46, 70, 298 |
185 |
CACNA2D2
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D11203
D11203
|
Mirogabalin
| 1件: 70 70 |
186 |
CACNA2D4
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
187 |
CACNA2D4
| 1件: Oxytocin signaling pathway Oxytocin signaling pathway | D02716
D02716
|
Pregabalin
| 5件: 13 13, 36, 46, 70, 298 |
188 |
ROCK2
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer | D07941
D07941
|
Fasudil
| 4件: 2 2, 5, 7, 51 |
189 |
ROCK2
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer | D11815
D11815
|
Belumosudil
| 1件: 51 51 |
190 |
CD38
| 3件: Oxytocin signaling pathway Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion | D10777
D10777
|
Daratumumab
| 5件: 16 16, 28, 49, 63, 222 |
191 |
CD38
| 3件: Oxytocin signaling pathway Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion | D11050
D11050
|
Isatuximab
| 2件: 28 28, 61 |
192 |
CD38
| 3件: Oxytocin signaling pathway Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion | D11945
D11945
|
Mezagitamab
| 1件: 66 66 |